BeatChildhoodCancer

We are a group of 40+ universities and children’s hospitals offering an international network of childhood cancer clinical trials. Partnered with @beatnb.

[BeatChildhoodCancer @NMTRC]

Every doctor except Dr. Giselle Sholler #beatnb #childhoodcancerawareness @GSholler @beatnb https://t.co/qeYrka7c9U

[The Boston Globe @BostonGlobe]

Every doctor told this father his son would die--except for one. https://t.co/otNACs2pSY

[BeatChildhoodCancer @NMTRC]

"Current treatment options for ETMR include surgical resection, systemic chemotherapy and... https://t.co/gSbCZ3rAKs

[BeatChildhoodCancer @NMTRC]

We could not be more grateful to the For Kids awake Foundation and the Jusczyk’s for their continued support!!! As a team we will make a difference for so many families!!! https://t.co/nTyYoWa4dM

[BeatChildhoodCancer @NMTRC]

Our heartfelt thanks to Megan and Glen for their incredible support of our research and trials. This is what FUELS our work here! Without support from the For Kids' Sake Foundation - created in honor of their daughter... https://t.co/cxipxgZsY5

[BeatChildhoodCancer @NMTRC]

We are pleased to announce that Dr.Kevin Ginn and his team at The Children’s Mercy Hospital, Kansas City, MO is now officially approved to enroll on NMTRC 012 “PEDS PLAN – Pediatric Precision... https://t.co/lZWwjOzVg4

[BeatChildhoodCancer @NMTRC]

We are pleased to announce that Dr.s Anurag Agrawal and Jennifer Michlitsch and their team at UCSF Benioff Children’s Hospital Oakland, Oakland, CA are now officially approved to enroll on NMTRC 012 “PEDS PLAN –... https://t.co/XhVz6CubYM

[BeatChildhoodCancer @NMTRC]

We are pleased to announce that Dr. Eugenia Chang and her team at St. Luke’s Mountain States Tumor Institute, Boise, ID are now officially approved to enroll on “PEDS PLAN – Pediatric Precision Laboratory Advanced... https://t.co/YMAn2yt2Il

[BeatChildhoodCancer @NMTRC]

What an incredible community supporting Harlow and Beat NB!! https://t.co/wVrQqOGLTc

[BeatChildhoodCancer @NMTRC]

Great news! Please join us in welcoming Dr. Meghen Browning and her team at Children’s Hospital of Wisconsin! They are now officially approved to enroll kids on our Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO). https://t.co/fsxmb2AbDf

[BeatChildhoodCancer @NMTRC]

A new study is coming...
The laboratory, genomic, and clinical research teams at Beat CC have been working incredibly hard to bring a new study to life. This study will be for children with DIPG. ETMR and ATRT using a... https://t.co/6U8zf08rlq

[BeatChildhoodCancer @NMTRC]

Our research, our trials, the sequencing and analysis of each child's tumor, the cost of DFMO for another child would never happen without all of the generous donors that partner with us to make this happen. Last week the... https://t.co/Hw6LFJccrV

[BeatChildhoodCancer @NMTRC]

We are proud to have Dr. Cornelius representing Beat CC and sharing the precision medicine work this team is doing in osteosarcoma at this important conference held by the MIB Agents Factor Foundation. https://t.co/VysLyvJ3gs

[BeatChildhoodCancer @NMTRC]

We are thrilled to be hosting a very special check presentation from the Beat Nb Foundation to Helen DeVos Children's Hospital for $1 million on Monday Jan 14th.

Patrick Lacey, founder of the Beat Nb Foundation has... https://t.co/qisIQmFRPn

[BeatChildhoodCancer @NMTRC]

https://t.co/w6nJ6HdVGX

[BeatChildhoodCancer @NMTRC]

Pat Lacey shared his story on the Sunday Today Show this morning. We are thankful to everyone who made this outcome possible, for Will and for many children since. Without everyone, this team... https://t.co/oC7iPQL688

[BeatChildhoodCancer @NMTRC]

Dr. Rebecca McFall and her team at Advocate Children’s Hospital-Oak Lawn, in Oak Lawn, IL are now officially approved to enroll patients on “PEDS PLAN – Pediatric Precision Laboratory Advanced... https://t.co/wz2MHEmcA0

[BeatChildhoodCancer @NMTRC]

Please join us in welcoming Dr. Doug Strother and his team at Alberta Children’s Hospital! They are now officially approved to enroll patients on “NMTRC 014 – Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)”. https://t.co/fsxmb2AbDf

[BeatChildhoodCancer @NMTRC]

We are excited to be expanding the focus of our research to include ETMR and DIPG and are already seeing exciting results coming from the lab! We’re so thankful to the The Jesse Heikkila Foundation for a $60,000 donation... https://t.co/lLhIgkFPrH

[BeatChildhoodCancer @NMTRC]

Our PLAN study helping children with Neuroblastoma from diagnosis with personalized care is spreading to help children across the... https://t.co/U9ogw8Gmak

[BeatChildhoodCancer @NMTRC]

Celebrating Halloween at family lab night with some spooky slime making and bubbling potions!

[BeatChildhoodCancer @NMTRC]

More fun news on Mia!! She is doing so well and heading back to school! https://t.co/UOIYE7kDzO